The Claim
In a 42-year-old woman with ulcerative colitis in remission, an eight-week intervention of 10/14 intermittent fasting (10-hour eating window, 14-hour fast) was associated with a 60% reduction in fecal calprotectin (from 139 to 51 mg/kg) and a 57% reduction in C-reactive protein (from 3.64 to 1.57 mg/L), along with self-reported symptom improvement, without significant changes in lipid, liver, or thyroid biomarkers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In a woman with ulcerative colitis in remission, following a 10-hour eating window and 14-hour fast for eight weeks was linked to lower levels of two inflammation markers in blood and stool, as well as improved symptoms, without affecting lipid, liver, or thyroid blood tests.
See the scientific wording
In a 42-year-old woman with ulcerative colitis in remission, eight weeks of 10/14 intermittent fasting (10-hour eating window, 14-hour fast) was associated with a 60% reduction in fecal calprotectin (from 139 to 51 mg/kg) and a 57% reduction in C-reactive protein (from 3.64 to 1.57 mg/L), alongside self-reported symptom improvement, without changes in lipid, liver, or thyroid biomarkers.
What the research says
1 studyStudy: Intermittent Fasting and Reduction of Inflammatory Response in a Patient with Ulcerative Colitis
A woman with a bowel condition tried eating only during a 10-hour window each day for two months, and her inflammation levels dropped a lot—she also felt better. The study shows this exact plan worked for her.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.